Dr. Cella on the Increase in Quality of Life Assessments
Dr. David Cella from Northwestern University Feinberg School of Medicine Explains the Increase in Quality of Life Assessments
David Cella, PhD, a clinical research specialist and chair of the Department of Medical Social Science at Northwestern University Feinberg School of Medicine in Chicago explains the overall increase in studies completing quality of life assessments.
Dr. Cella says the oncology community has more of a hunger for quality of life assessments. Patients appreciate being asked how they're doing. There used to be a fear that patients were being burdened by too many questions, but Dr. Cella says the opposite tends to be true. He says patients like being asked about their symptoms and their functioning. They like the fact that doctors care. There is some cost involved with getting the data as well as some risk involved in collecting the information because it may be found that a therapy does a good job of shrinking a tumor, but it could cause side effects that make a patient's life unbalanced and not much better.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
